Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 4.0

The market opened in red on April 22, 2021, overall volumes in futures & options currently stand at 4,56,59,667 contracts with a turnover of Rs. 41,71,483.21 crore.

Upper circuit stock: Wanbury with low P/E, now on verge of breakout
Upper circuit stock: Wanbury with low P/E, now on verge of breakout

Upper circuit stock: Wanbury with low P/E, now on verge of breakout

Shreya Chaware Article rating: 3.4

Several pharma stocks are rallying and Wanbury is just another lesser-known name that is attracting investors. According to BSE website, the company is trading at a P/E of 4, with a market cap (free float) of Rs 107 crore.  

Hero MotoCorp partners with Gogoro for developing electrical vehicles
Hero MotoCorp partners with Gogoro for developing electrical vehicles

Hero MotoCorp partners with Gogoro for developing electrical vehicles

Ganesh V Article rating: 4.5

Hero MotoCorp announced a strategic partnership with Gogoro Inc to accelerate the shift to sustainable electric mobility in India. The partnership aims to bring together Hero and Gogoro, the global leaders in urban battery swapping and smart mobility innovation.

IT giant TCS to help Wavin achieve business expansion in new growth markets
IT giant TCS to help Wavin achieve business expansion in new growth markets

IT giant TCS to help Wavin achieve business expansion in new growth markets

Abhinav Lahoti Article rating: 4.7

Tata Consultancy Services (TCS), a leading global IT services company announced its partnership with Wavin, Netherlands-based global innovative solutions provider for the building and infrastructure industry to expand in the markets of India & Indonesia. 

Vaishali Pharma climbs nearly 5 per cent on receiving supply orders worth Rs 2.02 crore
Vaishali Pharma climbs nearly 5 per cent on receiving supply orders worth Rs 2.02 crore

Vaishali Pharma climbs nearly 5 per cent on receiving supply orders worth Rs 2.02 crore

Shruti Dahiwal Article rating: 4.3

Vaishali Pharma Limited, a pharmaceutical company based in Mumbai, announced this morning that it has bagged an order worth Rs 2.02 crore from Afghanistan.  

As per the deal, the company will engage in the supply of active pharmaceutical ingredients (API), packaging material like capsules, glass vials, rubber stoppers, flip-off seals, and sterile water for injection, etc. It will also provide specific machinery setups such as tablet manufacturing machines.

L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia
L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia

L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia

Apurva Joshi Article rating: 4.7

The buildings & factories business of Larsen & Toubro Construction has secured a significant contract from Oilfields Supply Company in Saudi, owned by Dubai-based Oilfields Supply Center Ltd to design and build one of the world's largest oil & gas supply bases at King Salman Energy Park, Dammam (Kingdom of Saudi Arabia). 

Is Lupin set for a breakout?
Is Lupin set for a breakout?

Is Lupin set for a breakout?

Vinayak Gangule Article rating: 4.0

One of the largest generic pharmaceutical companies by revenue globally, Lupin Limited is poised for a technical breakout on the daily chart. Read onto know what the momentum indicators and volumes are suggesting about the stock.

Fourteen stocks that may witness action on Thursday
Fourteen stocks that may witness action on Thursday

Fourteen stocks that may witness action on Thursday

Karan Dsij Article rating: 3.5

AstraZeneca: AstraZeneca Pharma India Limited has launched Fasenra™ in India. Benralizumab (Fasenra™) is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients.   

RSS
First23742375237623772379238123822383Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR